Internal Medicine, Rheumatology · Mooresville, NC
NPI
1619976479
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
128 Medical Park Rd, Suite 101
Mooresville, NC, 28117
Phone (704) 658-1001
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.6M
121,269 services
Medicare patients, 2024
467
Average age 74
Drug cost, 2024
$2.8M
4,970 prescriptions
Company payments, 2025
$67.79
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sean M Fahey was code J0129 (injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 13,525 times for 21 patients. In total Sean M Fahey billed 121,269 services in 78 codes, and Medicare paid $1.6M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-08.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 13,525 | 21 | $33.87 | $458K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 9,600 | 12 | $9.07 | $87K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 6,690 | 18 | $24.85 | $166K |
| J0897 Injection, denosumab, 1 mg | Office | 6,540 | 71 | $20.53 | $134K |
| 99213 Office E&M - Established | Office | 640 | 249 | $65.33 | $42K |
| 36415 Venipuncture Blood Collection | Office | 566 | 255 | $8.60 | $4,870 |
| 85652 Clinical Chemistry | Office | 537 | 230 | $2.61 | $1,403 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 486 | 275 | $12.24 | $5,947 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 460 | 64 | $0.51 | $234 |
| 80076 Clinical Chemistry | Office | 393 | 141 | $7.87 | $3,094 |
| 86140 Clinical Chemistry | Office | 389 | 202 | $4.98 | $1,937 |
| 85027 Blood Count | Office | 339 | 122 | $6.21 | $2,105 |
| 99214 Office E&M - Established | Office | 332 | 191 | $87.02 | $29K |
| 96365 Intravenous Infusion, Hydration | Office | 260 | 51 | $43.87 | $11K |
| 82565 Clinical Chemistry | Office | 255 | 124 | $4.90 | $1,250 |
By year: 2022 $2.1M for 121,759 services; 2023 $1.6M for 118,243 services; 2024 $1.6M for 121,269 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 566 | 255 | $8.60 | $4,870 |
| 85652 Clinical Chemistry | 537 | 230 | $2.61 | $1,403 |
| 80076 Clinical Chemistry | 393 | 141 | $7.87 | $3,094 |
| 86140 Clinical Chemistry | 389 | 202 | $4.98 | $1,937 |
| 85027 Blood Count | 339 | 122 | $6.21 | $2,105 |
| 82565 Clinical Chemistry | 255 | 124 | $4.90 | $1,250 |
| 86160 Immunoassay | 109 | 40 | $11.54 | $1,258 |
| 82550 Clinical Chemistry | 80 | 60 | $6.30 | $504 |
| 85025 Blood Count | 71 | 45 | $7.46 | $530 |
| 82306 Clinical Chemistry | 24 | 24 | $29.01 | $696 |
Medicare prescription drug claims, 2024
In 2024, the drug Sean M Fahey prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,036 prescriptions and refills. In total Sean M Fahey wrote 4,970 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,036 | 2,009 | 270 | $31K |
| Prednisone Generic | 773 | 861 | 326 | $5,821 |
| Methotrexate Methotrexate Sodium | 356 | 691 | 103 | $7,854 |
| Leflunomide Generic | 226 | 372 | 59 | $9,499 |
| Sulfasalazine Generic | 192 | 329 | 71 | $5,131 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 188 | 188 | 41 | $4,288 |
| Tramadol Hcl Generic | 177 | 191 | 47 | $1,758 |
| Gabapentin Generic | 144 | 254 | 39 | $3,504 |
| Celecoxib Generic | 133 | 206 | 47 | $2,164 |
| Pregabalin Generic | 84 | 114 | 23 | $1,498 |
| Meloxicam Generic | 83 | 138 | 24 | $499 |
| Baclofen Generic | 82 | 136 | 37 | $1,424 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 76 | 76 | 17 | $1,692 |
| Duloxetine Hcl Generic | 75 | 154 | 21 | $1,538 |
| Allopurinol Generic | 72 | 165 | 22 | $622 |
Brand drugs: 564 claims; generic drugs: 4,406 claims; opioid claims: 519.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sean M Fahey $67.79 ($67.79 in general payments such as food, travel and fees) from 3 companies. The largest payer was Janssen Biotech, Inc. with $29.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.